Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes
about
HIV-1 and IL-1β regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-κB signaling mechanismsInteractions of Opioids and HIV Infection in the Pathogenesis of Chronic PainDengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell deathMechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersHIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes.Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes.Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription.Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.Molecular pathways in virus-induced cytokine production.Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statinsMolecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein.Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS.NF-kappaB and virus infection: who controls whom.HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDSActivation of microglia by borna disease virus infection: in vitro studyMolecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells.Caprine arthritis encephalitis virus dysregulates the expression of cytokines in macrophages.Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.Opiate drug use and the pathophysiology of neuroAIDS.Nuclear factor kappaB signaling in opioid functions and receptor gene expressionDifferences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicityComparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.Roles of MCP-1 in development of HIV-dementia.Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.Mass spectrometric phosphoproteome analysis of HIV-infected brain reveals novel phosphorylation sites and differential phosphorylation patterns.SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1.Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes.HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways.Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes.
P2860
Q24294630-73C0430A-4941-4D19-8330-0CB23539099AQ26768068-40B25524-1463-4383-BA2C-6407FCE45E74Q27480811-A7BE49E1-C30A-4B4B-AE40-0CCBEC95508DQ28082139-C3F31519-F1F8-4549-AA63-C5E014432C61Q33455734-0996F8CE-CF99-4E42-87D5-EE1065B65B0BQ33604853-607A4739-1DD2-4B0A-B2BB-767837BE85C2Q33654155-0D73DCB2-2EA4-44D7-A1F9-534D11843CB1Q33770575-78C07E04-9134-4FEF-869B-632C4FE62815Q33797102-24C0A745-CFB6-48A4-B0A1-23BC875DF95CQ33897742-4C47F5D8-A875-4DF0-8A42-9CB99DD66BBDQ34174972-197027AE-550C-412D-9E58-357D67620A99Q34264444-43BAC4E6-15B1-4A72-A6A7-E0366D08FE5FQ34998247-078E7AA7-091F-453E-90B0-3E09042E032DQ35007339-1F9B2FC7-697B-4343-8147-1531FDF5DBA4Q35024694-AEF5AB20-0662-4829-A006-CC30EAA4D37BQ35054688-071BABCF-B260-4970-AA65-EBFBE4A8A391Q35139535-64758D7A-AFF4-41B0-AD39-9EED7F7E587FQ35150753-FA5F0346-2046-467A-B30E-8B668AD777E5Q35185949-5ECD03C2-AF0A-4D3F-82B5-B866E11BABDEQ35879801-3A1AAAC0-ADD9-4E7E-BFDE-268B25CEF998Q35895488-E5D2415E-713E-4D12-8442-79C62FEED696Q35980114-A48D5B68-8352-4195-9A34-0EE7022A53FBQ36201412-8EE9A94C-5B15-4D20-8002-3F5DCEFD34EEQ36245077-D25E5BEE-C6A6-4A5F-8DB0-C5312AF0F46DQ36296748-698D201C-DA34-4124-AA92-AF02AAD68F72Q36961218-ACB3E2F8-7F5D-43AB-9B78-6180BBBC7538Q37175209-96BED503-E04C-45E7-A07F-7EDFD2DC9FE5Q37347813-D1DEE5B8-DA76-4A6F-85F0-AD70BA9CE506Q37401992-1768C22A-E284-4A32-A15D-E02EC6512057Q39855918-BE51A33E-164E-42D3-8448-9219A91DEE95Q39921141-D4FDF470-28D8-42E0-838F-28BB945941B4Q42097093-67BC455F-6B38-405C-90E0-2DAA75F6DC13Q43131684-B0D1B92A-E42F-46DD-B0B7-09C79B1D0506
P2860
Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
Extracellular human immunodefi ...... ty in primary human astrocytes
@ast
Extracellular human immunodefi ...... ty in primary human astrocytes
@en
Extracellular human immunodefi ...... ty in primary human astrocytes
@nl
type
label
Extracellular human immunodefi ...... ty in primary human astrocytes
@ast
Extracellular human immunodefi ...... ty in primary human astrocytes
@en
Extracellular human immunodefi ...... ty in primary human astrocytes
@nl
prefLabel
Extracellular human immunodefi ...... ty in primary human astrocytes
@ast
Extracellular human immunodefi ...... ty in primary human astrocytes
@en
Extracellular human immunodefi ...... ty in primary human astrocytes
@nl
P2093
P2860
P921
P1433
P1476
Extracellular human immunodefi ...... ty in primary human astrocytes
@en
P2093
P2860
P304
P407
P577
1996-03-01T00:00:00Z